A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

BACKGROUND: We previously reported that low-dose, short-course sunitinib prior to neoadjuvant doxorubicin-cyclophosphamide (AC) normalised tumour vasculature and improved perfusion, but resulted in neutropenia and delayed subsequent cycles in breast cancer patients. This study combined sunitinib wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Ang, Yvonne L. E., Ho, Gwo Fuang, Soo, Ross A., Sundar, Raghav, Tan, Sing Huang, Yong, Wei Peng, Ow, Samuel G. W., Lim, Joline S. J., Chong, Wan Qin, Soe, Phyu Pyar, Tai, Bee Choo, Wang, Lingzhi, Goh, Boon Cher, Lee, Soo-Chin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672922/
https://ncbi.nlm.nih.gov/pubmed/33203399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07616-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados